Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Tihomir V. Ilić"'
Autor:
Milorad Dragić, Milica Zeljković, Ivana Stevanović, Marija Adžić, Andjela Stekić, Katarina Mihajlović, Ivana Grković, Nela Ilić, Tihomir V. Ilić, Nadežda Nedeljković, Milica Ninković
Publikováno v:
Brain Sciences, Vol 11, Iss 6, p 736 (2021)
Multiple sclerosis (MS) is a chronic neurodegenerative disease caused by autoimmune-mediated inflammation in the central nervous system. Purinergic signaling is critically involved in MS-associated neuroinflammation and its most widely applied animal
Externí odkaz:
https://doaj.org/article/0e601c8c5f834205b5a2cb811318b275
Autor:
Sofija Spasojević, Tihomir V. Ilić, Ivan Stojković, Veljko Potkonjak, Aleksandar Rodić, José Santos-Victor
Publikováno v:
Frontiers in Neurology, Vol 8 (2017)
We present an approach for quantitative assessment of the arm/hand movements in patients with Parkinson’s disease (PD), from sensor data acquired with a wearable, wireless armband device (Myo sensor). We propose new Movement Performance Indicators
Externí odkaz:
https://doaj.org/article/4a5f64d84a614e8aac4af8ce82b6c988
Autor:
Begonya eOtal, Anirban eDutta, Águida eFoerster, Oscar eRipolles, Amy eKuceyeski, Pedro Cavaleiro Miranda, Dylan J. Edwards, Tihomir V. Ilić, Michael A. Nitsche, Giulio eRuffini
Publikováno v:
Frontiers in Neurology, Vol 7 (2016)
Stroke is a leading cause of serious long-term disability worldwide. Functional outcome depends on stroke location, severity and early intervention. Conventional rehabilitation strategies have limited effectiveness, and new treatments still fail to k
Externí odkaz:
https://doaj.org/article/5fc225f4cf2a4ea49d7ba8b56e7fea32
Autor:
Nela V. Ilić, Tihomir V. Ilić, Mirjana Sovilj, Ivana Stankovic, Ljiljana Jeličić, Miško Subotić, Vesna Martic, Miodrag Stokić
Publikováno v:
Vojnosanitetski pregled (2022) 79(3):215-220
Background/Aim. Neurofeedback (NFB) is a therapeutic method based on monitoring the electroencephalogram (EEG) and providing feedback on the brain activity of sub-jects. The aim of the pilot study was to investigate the effect of lower-beta or sensor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a680e24b98316ed37c517b0362742ebc
http://scindeks.ceon.rs/article.aspx?artid=0042-84502203215S
http://scindeks.ceon.rs/article.aspx?artid=0042-84502203215S
Autor:
Nela V. Ilić, Katarina Mihajlović, Milica Ninkovic, Nadežda Nedeljković, Andjela Stekić, Marija Adžić, Tihomir V. Ilić, Milorad Dragić, Milica Zeljkovic, Ivana Grković, Ivana Stevanovic
Publikováno v:
Brain Sciences, Vol 11, Iss 736, p 736 (2021)
Brain Sciences
Volume 11
Issue 6
Brain Sciences
Volume 11
Issue 6
Multiple sclerosis (MS) is a chronic neurodegenerative disease caused by autoimmune-mediated inflammation in the central nervous system. Purinergic signaling is critically involved in MS-associated neuroinflammation and its most widely applied animal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13239443dcaf44c93862c4f529ec525c
https://www.mdpi.com/2076-3425/11/6/736
https://www.mdpi.com/2076-3425/11/6/736
Autor:
Bojana Mancic, Petar Milosavljevic, Ivana Stojanovic, Irena Lavrnja, Milica Ninkovic, Ivana Stevanovic, Tihomir V. Ilić
Publikováno v:
Folia Neuropathologica, Vol 57, Iss 2, Pp 129-145 (2019)
Folia Neuropathologica
Folia Neuropathologica
Repetitive transcranial magnetic stimulation (rTMS) induces changes in expression of proteins engaged in the activity of excitatory and inhibitory systems, restores these functions and suppresses the progression of disability in experimental autoimmu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae8cc7a0d897ed8c3fa47c4e92fc580
https://doi.org/10.5114/fn.2019.86294
https://doi.org/10.5114/fn.2019.86294
Autor:
Mirjana Djukic, Milica Ninkovic, Bojana Mancic, Marija Milivojevic, Maja Vujovic, Ivana Stevanovic, Tihomir V. Ilić, Ivana Stojanovic
Publikováno v:
Molecules
Molecules, Vol 25, Iss 3922, p 3922 (2020)
Volume 25
Issue 17
Molecules, Vol 25, Iss 3922, p 3922 (2020)
Volume 25
Issue 17
Cortical theta burst stimulation (TBS) structured as intermittent (iTBS) and continuous (cTBS) could prevent the progression of the experimental autoimmune encephalomyelitis (EAE). The interplay of brain antioxidant defense systems against free radic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef0c15215db35dd2d136b702bc49e06
https://pubmed.ncbi.nlm.nih.gov/32867364
https://pubmed.ncbi.nlm.nih.gov/32867364
Autor:
Milorad Dragić, Ivana Stevanovic, Nadezda Nedeljkovic, Milica Zeljkovic, Tihomir V. Ilić, Milica Ninkovic, Nela V. Ilić
Publikováno v:
Brain Research Bulletin
Multiple sclerosis (MS) is a chronic neurodegenerative disease caused by inflammatory processes in the central nervous system (CNS). Decades of research led to discovery of several disease-modifying therapeutics strategies with moderate success. Expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e15db27281da726433ea7b9b8067c63
https://pubmed.ncbi.nlm.nih.gov/32599126
https://pubmed.ncbi.nlm.nih.gov/32599126
Autor:
Hubert H. Fernandez, Tihomir V. Ilić, James C. Norton, David L Kreitzman, Srdjan Stankovic, Jean-Philippe Azulay, Stuart Isaacson, Clive Ballard, Bruce Coate, Victor Abler, Joaquim J. Ferreira
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
© 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
Introduction: Pimavanserin, a selective 5-HT2A inverse agonist/antagonist, was approved for hallucinations and delusions associated w
Introduction: Pimavanserin, a selective 5-HT2A inverse agonist/antagonist, was approved for hallucinations and delusions associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e9bd59836a830420547e27197b6fc6
https://pubmed.ncbi.nlm.nih.gov/33933853
https://pubmed.ncbi.nlm.nih.gov/33933853
Autor:
Stuart Isaacson, Srdjan Stankovic, Tihomir V. Ilić, George Demos, David L Kreitzman, Jean-Philippe Azulay, Hubert H. Fernandez, I-Yuan Liu, James C. Norton, Clive Ballard, Joaquim J. Ferreira, Victor Abler
Publikováno v:
Parkinsonismrelated disorders. 77
Introduction Pimavanserin is a selective 5-HT2A inverse agonist/antagonist approved for treating hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Results from short-term, placebo-controlled studies demonstrated a posi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ecc69e48edbd26f79f9f3d1bb0292fa
https://pubmed.ncbi.nlm.nih.gov/32712560
https://pubmed.ncbi.nlm.nih.gov/32712560